KINGSTON, RI October 18, 2023 The University of Rhode Island has appointed Kerry LaPlante, an internationally recognized expert on antibiotic resistance and infectious diseases, as the next dean of the College of Pharmacy. LaPlante, who currently serves as department chair and professor of pharmacy at URI, becomes the first female dean of the college of pharmacy.
“We are delighted that Kerry will assume this new leadership position at the University,” said Barbara E. Wolfe, provost and executive vice president for academic affairs at URI. Kerry is a longtime and highly regarded member of our URI community. But her significant contributions extend far beyond our campus. She is a leading voice on health care and policy in our state, and her extensive research and clinical experience contribute to the global conversation and understanding of resistance. birth and infectious diseases.
The eighth dean of the College of Pharmacy, LaPlante succeeds Paul Larrat, who led the school for more than a decade and earlier this year announced his intention to return to the faculty. “I want to thank Paul for his dedicated, selfless leadership as president of the college and for helping solidify the College of Pharmacy’s position as a national leader,” Wolfe said. ”.
LaPlantes’ appointment follows a comprehensive and competitive national search. Her term will begin on January 2, 2024.
A licensed clinical pharmacist, LaPlante is an internationally recognized expert on antibiotic use, antibiotic resistance, and health policy implementation. Throughout her scientific and clinical career, she has published more than 140 peer-reviewed research articles, and she has received ongoing funding from more than 30 successfully awarded research grants totaling more than $21 million as principal or co-investigator from the National Institutes of Research. Health, Department of Veterans Affairs and research departments in the pharmaceutical industry.
Her primary research expertise is in infectious diseases, especially the treatment and prevention of a variety of drug-resistant bacteria, including Methicillin-resistant Staphylococcus Aureus (MRSA) and related infections. She said the overall goal of her research and clinical work is to improve the health of the community, always focusing on the patient.
LaPlante said her vision for universities revolves around fostering an environment of inclusion, diversity and limitless opportunity.
Pharmacists, as medication and safety experts in health care, play an important role in the health and well-being of patients, she said. The future of pharmacy practice and pharmaceutical science represents endless opportunities, where innovation, compassion and expertise come together to redefine healthcare. Strong. As dean, I intend to continue the tradition of excellence in education and research that has long been established at our university, making groundbreaking discoveries and preparing the next generation of leaders. next health care director.
LaPlante joined URI in 2004 as an associate professor of pharmacy, becoming a full professor in 2015. She was appointed dean of pharmacy practice in 2020 and has played a prominent role in expanding and enhance the university’s research program, which ranks among the top 10 percent of funding among colleges of pharmacy in the country. URI is proud to be the top pharmacy school in New England for research funding.
“I am delighted to pass the baton to Kerry,” said Larrat. She was a wonderful colleague, a thoughtful leader, a dedicated collaborator, and a good friend for many years. I look forward to our university’s continued success under her guidance.
LaPlante, a native of Buffalo, New York, discovered his passion for pharmacy while working at a local independent pharmacy. She serves as director of the Infectious Disease Research Program at the Providence VA Medical Center, and is an infectious disease therapist at the VA, and an adjunct professor of infectious diseases at the School of Medicine Warren Alpert of Brown University. She is chair of the Rhode Island Department of Health’s Environmental and Antimicrobial Stewardship Task Force, where she leads the Antimicrobial Stewardship Expansion Initiative across acute care, long-term care facilities term and urgent care statewide. She is a consultant to the Centers for Disease Control and Prevention, PEW Research Center, and the Joint Commission, which accredits and certifies health care organizations nationwide.
LaPlante served as director of the Pharmacology Core of Rhode Island’s NIH-COBRE Center for Antimicrobial Resistance and Treatment Discovery; member of the NIH-NIAID Antimicrobial Resistance Leadership Group; elected member of the Infectious Diseases Society of America and the American College of Clinical Pharmacy; and former president of the Society of Infectious Disease Pharmacists (SIDP). She directs a training fellowship program at the Providence Veterans Affairs Health Care System; and vice president of Making a Difference in Infectious Diseases (MAD-ID), a national nonprofit health organization; and is associate editor of the journal Clinical Infectious Diseases.
A prominent leader in local and global health care policy, LaPlante played a key public role during the height of the COVID-19 pandemic and was appointed by Rhode Island’s governor. Responsible for COVID-19 vaccine subcommittee.
LaPlante earned his Doctor of Pharmacy degree from Wayne State University’s Eugene Applebaum College of Pharmacy and Health Sciences in Detroit MI and his bachelor’s degree in biology from Canisius College in Buffalo NY.
#URI #names #Kerry #LaPlante #dean #College #Pharmacy
Image Source : www.uri.edu